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Abstract
Background: Individuals routinely receive information about their risk of coronary heart disease (CHD) based on
traditional risk factors as part of their primary care. We are also able to calculate individual’s risk of CHD based on
their genetic information and at present genetic testing for common diseases is available to the public. Due to
the limitations in previous studies further understanding is needed about the impact of the risk information on
individual’s well-being and health-behaviour. We aimed to explore the short term response to receiving different
forms of CHD risk information and lifestyle advice for risk reduction.
Methods: We conducted fourty-one face-to-face interviews and two focus groups across England with participants
from the INFORM trial who received a combination of individualised phenotypic and genotypic CHD risk scores and
web-based lifestyle advice. Risk scores were presented in different formats, e.g. absolute 10 year risk was presented
as a thermometer and expressed as a percentage, natural frequency and ‘heart age’. Interviews and focus groups
explored participants’ understanding and reaction to the risk scores and attempts to change lifestyle during
the intervention. We tape-recorded and transcribed the interviews and focus groups and analysed them using
thematic analysis.
Results: Three main themes were identified: limitations of risk scores to generate concern about CHD risk; the
advantages of the ‘heart age’ format of risk score presentation in communicating a message of sub-optimal
lifestyle; and intentions and attempts to make moderate lifestyle changes which were prompted by the web-based
lifestyle advice.
Conclusions: There are a number of limitations to the use of risk scores to communicate a message about the
need for a lifestyle change. Of the formats used, the ‘heart age’, if noticed, appears to convey the most powerful
message about how far from optimal risk an individual person is. An interactive, user friendly, goal setting based
lifestyle website can act as a trigger to initiate moderate lifestyle changes, regardless of concerns about risk scores.
Trial registration: Current Controlled Trials ISRCTN17721237. Registered 12 January 2015.
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Background
Cardiovascular disease (CVD) is the leading cause of
death globally [1], responsible for a third of all deaths
[2]. Approximately 17.3 million people worldwide died
from CVD in 2013 [3]. It is estimated that by 2030, 23.3
million people per year will die as a result of CVD [4].
Many risk factors, such as smoking, an unhealthy diet,
and lack of physical activity, are modifiable and therefore
effective preventive strategies targeting these factors can
lead to a reduction in the frequency of CVD [5, 6]. Even
modest changes in lifestyle, if adopted by a significant
proportion of the population, have the potential to re-
duce global CVD by half [7].
One widely adopted preventive strategy is the assess-
ment of CVD risk of individuals. CVD risk information
is used by physicians to inform decisions about treat-
ment, and is given to patients to encourage lifestyle
changes, including taking appropriate medication in
order to reduce CVD risk [8–12]. There are many differ-
ent ways to communicate risk information. Numerical
expressions may include percentages, natural frequencies
and numbers needed to treat while graphical presenta-
tions include bar graphs and pictograms or icon arrays
[13]. In an attempt to develop a more intuitive and easy
to understand method of presenting CVD risk, the for-
mat of ‘heart age’ [14], sometime known as ‘vascular
age’ [15] was developed. Although different studies have
defined and measured ‘heart age’ differently [15], most
commonly an individual’s ‘heart age’ is the age in which
someone with healthy risk factors will have (according
to existing population reference values) the same CVD
risk which this individual has now.
Systematic reviews of randomised controlled trials and
before-and-after studies have shown that the provision
of phenotypic CVD risk information improves people’s
accuracy of perceived risk [16, 17] but has little effect on
lifestyle [16]. There are very few studies exploring the
mechanism for this lack of effect on lifestyle. Theories of
health behaviour change such as Health Belief model
[18], Protection Motivation Theory [19], or the Theory
of Planned Behaviour [20] refer to elements of perceived
risk or threat as one link in a chain of thoughts and re-
actions that may lead to behaviour change. However,
while in some of the early theories such as the Health
Belief model the perception of the risk was considered a
key element likely to lead to process of change, most
theories now suggest that many other determinates can
affect, induce or prevent different stages of the creation
of intentions to change and then actual change [21, 22].
There are several additional explanations for this lack
of effect of provision of risk information on lifestyle
change. Firstly, many of the previous studies were small
and relied on imprecise self-report measures [13]; sec-
ondly due to limitations in previous studies the optimal
format for communication of CVD risk is not known
[13, 23–25]. However, there is evidence that presenting
risk both graphically and numerically can lead to more
accurate risk perceptions, to favourable changes in risk
factors and can help reduce negative emotions [13]. Evi-
dence for the effects of the ‘heart age’ format is scarce
[15]. One recent randomised controlled trial found
‘heart age’ to be more effective than other types of indi-
vidual’s modelled CVD risk in reducing risk scores [24].
Two studies, one experimental [26] and one qualitative
[27] have found decreased perceived credibility for risk
scores presented in this way, although the latter found it
could still motivate lifestyle change. With increasingly
available genetic data it has also been suggested that
CVD risk information might be more effective when
based on genetic information [28–30]. However two
recent systematic review of provision of genetic risk
found no clear or consistent evidence that genetic
risk communication alone either raises motivation or
translates into actual lifestyle change [29, 31]. And
many questions remain about the feasibility, accuracy,
interpretation and potential harm of providing genetic
risk scores [32, 33].
Most qualitative studies exploring the use of CVD risk
scores have focused on general practitioners and the
consultation process [34–37]. The small number of
studies involving the general public have focused on
their immediate reaction to risk information in order to
identify either their preferences regarding different for-
mats of presentations [38], or their prediction of its
potential impact on their future decision making [39].
Only one recent qualitative study focused on the impact
of providing genetic risk information [40].
The Information and Risk Modification Trial (INFORM)
[41] is a randomised controlled trial comparing the impact
of providing phenotypic and genetic coronary heart disease
(CHD) risk scores, alongside web-based lifestyle advice. In
addition to objective and self-report measures at baseline
and follow up, the study also included face-to-face inter-
views and focus groups which took place throughout the
trial. We aimed to explore participant responses to differ-
ent types of risk information as well as considerations in-
volved in intentions to change or not to change lifestyle
and attempts to implement these intentions. This paper re-
ports the results from this qualitative study nested within
that trial.
Methods/Design
The trial
The design and methods of the INFORM study are de-
scribed in detail elsewhere [41]. Briefly, INFORM is a
parallel-group, open randomised trial in which male and
female blood donors with no previous history of CVD
aged 40–84 years from across England, who took part in
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the INTERVAL study [42], were allocated to either no
intervention (control group, group 1), or to one of three
active intervention groups: lifestyle advice only (group 2);
lifestyle advice plus information on estimated 10-year
CHD risk based on phenotypic characteristics (group 3);
and lifestyle advice plus information on estimated
10-year CHD risk based on phenotypic and genetic
characteristics (group 4). Lifestyle advice consisted of three
sessions of interactive, tailored web-based information [41].
The intervention
Participants in all three intervention groups were pro-
vided by email with a link to a web-based lifestyle inter-
vention for CHD prevention based on an intervention
that was originally developed for the Heart to Health
study [43]. The lifestyle intervention consisted of three
sessions of interactive, tailored information (up to three
hours of interventional contact) with goal setting at the
end of each session and some interactive information to
help participants overcome individual challenges pre-
venting them from changing their lifestyle.
Following a ‘welcome page’, participants from groups 3
and 4 received information about their risk in a format
described below, while participants from group 2 (life-
style only), after receiving some general information
about CHD risk and the potential of lifestyle changes to
reduce it, went directly to the lifestyle advice modules
(either diet, physical activity or smoking) in which they
could choose which modules they wanted to do.
All the participants in the two intervention groups that
received risk scores, received a link to a website where
their risk scores were presented in the following four
ways (participants in group 4 received these four types
of presentation twice, once for the phenotypic score and
once for the genetic one):
1. Absolute risk of having either a fatal or nonfatal
CHD event during the next 10 years, as a percentage
with accompanying text explaining what this means
(“Your risk of having coronary heart disease in the
next 10 years is 31%. This means that approximately
31 out of 100 women like you (31%) will experience
coronary heart disease in the next 10 years”).
2. A visual representation of the risk. For that purpose
we used a thermometer with three colours, red for
high risk above 20%, yellow for moderate risk above
10%, and green for risk under ten percent. An
arrow indicated the level of risk. When designing
the thermometer we took into account the
recommendations by NICE guidelines [44] that
advise offering statins to people with a 10 year
risk >10% and the AHA guidelines advise offering
statins to people with a 10 year risk >7.5%. The low
risk (indicated as green) was defined as below 7.5%
and then graded to orange (between 7.5–10%) and
then graded to red at 20% and above.
3. Peer comparative risk which is the risk of someone
who is the same age and sex and has healthy
lifestyle-related factors known to be associated with
CHD risk.
4. To help people to understand what their absolute risk
means we expressed their absolute risk in terms of
‘heart age’. For the purposes of this study, an
individual’s ‘heart age’ is defined as the age in which
someone with healthy risk factors will have (according
to existing population reference values) the same
CVD risk which this individual has now [41].
We have described the calculation of the phenotypic and
genetic risk scores in detail elsewhere [41]. As we state
there: ‘we have included the following set of variables: age,
total cholesterol (mmol/l), HDL cholesterol (mmol/l),
antihypertensive medication (self-reported yes/no), current
smoking (self-reported yes/no) and diabetes mellitus (self-
reported yes/no. We chose CHD instead of CVD as the
outcome for the risk scores since the majority of genomic
loci known to relate to CVD are associated with CHD
(rather than stroke) [41]. The Heart Age for phenotypic
risk score was derived from the same general formula as
used for the absolute risk score, rearranged such that age is
unknown, other risk factors are normal and absolute risk is
that of the participant in question. The definition of
“normal” was based on the following profile: not a current
smoker, does not have diabetes, not using antihypertensive
medication, total serum cholesterol = 4.6548 mmol/l and
HDL cholesterol = 1.1637 mmol/l [23]. Healthy lifestyle-
related factors were defined as follows: a) current non-
smokers (i.e. never smoked and former smokers) [33]; b)
moderate levels of alcohol consumption (one or more
units a week but not more than fourteen units a week; 1
unit = 8 g) [33]; c) consumption of fruit and vegetables
(more than 400 g) [34]; d) consumption of fish (a portion
size of 140 g cooked weigh (20 g/day) [35]; e) consump-
tion of red meat (≤6 portions a week, equivalent to ≤500 g
of cooked weight or 71 g per day [36]; f ) physical activity
(not inactive, at least half an hour of leisure-time activity a
day) [33]; g) body mass index (BMI) <25 kg/m2’.
In line with the phenotypic risk score, we estimated
mathematical CHD functions to predict 10-year risk of
CHD using a similar general formula. For the absolute
genetic risk score, this formula was plugged with the
same baseline cumulative hazard as the absolute pheno-
typic risk score, individual lnGRS and the mean lnGRS.
For the purpose of ‘heart age’, normal lnGRS was
defined as the sex-specific 10th centile (<1.043 for
males, <1.045 for females). This calculation meant that
participants could have received heart age that was older
or younger than their actual age [41].
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All forms of presentation were based on evidence re-
garding the effectiveness of methods for communicating
CHD risk estimates which we described above and after
consulting with layperson PPI (Patients and Public
Involvement in Research) representatives. Examples of a
page with all formats of presentations appear in
Additional file 1A (for phenotypic risk score) and Additional
file 1B (for genetic risk scores). A time frame of the next
10 years was selected in line with timeframe used in NHS
Health Checks and the Framingham risk score that we
used for calculation of phenotypic risk score [45]. A use of
shorter time frame than 10 years (e.g. 5 years) usually pro-
vides a small absolute risk estimates especially among
those who are younger.
The qualitative data collection
We sent invitations to take part in the interviews and
focus groups to a purposive sample selected from partic-
ipants who had given their consent to be approached
about the qualitative study when completing the online
consent form to take part in the trial. We recruited a
diverse sample in terms of sex and age. However, in
order to sample participants who could provide the
richest information relating to our main research ques-
tions, we recruited mainly participants who received risk
scores, with over representation of participants with
medium to high risk (who in theory may have stronger
motivation to change lifestyle). From every 100 partici-
pants who were recruited to the trial and expressed will-
ingness to take part in the study we sent invitations to
participants with an absolute risk (either phenotypic or
genetic or both) of above 10% and to participants whose
‘heart age’ (phenotypic or genetic) was at least two years
older than their real age. In the earlier stages of re-
cruitment (the first 200 participants) we additionally
recruited several participants with an absolute risk be-
tween 5–10%. Our reason for choosing this sampling
strategy was that the risk score of people who have high
absolute risk score and/or a ‘heart age’ older than their
chronological age may have an additional incentive/
motivation for change because it carries a warning mes-
sage. Given the geographic spread of the trial participants
all over England, we identified two large cities in the
North of England that had enough participants to form a
focus group that can be located within a realistic driving
distance for each participant. The rest were of the partici-
pants interviewed individually. Participants took part in
either the personal interviews or focus groups, but not
both. GS, an experienced qualitative researcher, conducted
all the interviews following a topic guide. Each interview
lasted between 30–45 min and covered issues related to
the participants’ understanding of CVD risk, their reaction
to the risk score, their intentions to change behaviour,
their attempts at actually changing behaviour if present,
and other aspects of their experience of taking part in the
trial. GS and BS conducted the focus groups. They lasted
between 60–90 min and mainly covered issues related to
the formats of presentation of risk scores, and communi-
cation and understanding of CVD risk. Accordingly, in the
focus groups, after discussing their personal experience of
the trial, we provided the participants with a copy of
fictional risk scores page, in the same format used in the
website in order to discuss preferences and understand-
ings of specific formats of presentations.
Analysis
We undertook thematic analysis of the qualitative data
coding transcripts using NVivo software. To increase the
rigour and validity of the analysis, and as a form of tri-
angulation, three members of the team (GS, BS and JUS)
developed the coding tree. A subset of 5 transcripts was
then coded separately by each of these three researchers
and disagreements discussed between them in order to
reach consensus about interpretation and indexing. The
same thematic framework was applied to the interviews
and focus groups. The final coding tree can be seen as
Additional file 2. The coding (indexing of excerpts of the
data into different categories or codes) for the remainder
of the transcripts was conducted by one researcher (GS)
following the principles discussed and agreed between
the three researchers. This was followed by an interpret-
ation stage of reading through the coded categories and
defining the main concepts and mapping the ways in
which different parts of the data were related to each
other. We sent a summary of the findings (a short sum-
mary of each of the three main themes described below)
to all qualitative participants by email as a form of
further validation and their comments were taken into
account when writing the final draft of the manuscript.
Results
Interviews and focus groups recruitment
Forty two interviews were conducted between June 1st
and October 1st 2015. Most participants were from
London, East Anglia and the East Midland areas al-
though a small number were from North West England.
Interviews were conducted between 1 and 134 days
(median: 40 days) after participants had first accessed
the website (based on information collected by the
website). Two focus groups, one with six participants
and one with seven participants we conducted. The
median time between participants first accessing the
website and taking part in the focus group was 101 days.
One of the participants asked at a later date to be
withdrawn from the study and for the related data to be
withdrawn as well and we did so regarding this qualita-
tive interview as well.
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The characteristics of participants are shown in Table 1
(other baseline information of the participants in the
qualitative study appear in Additional file 3) .
Findings
Three main themes were identified. First, there are various
challenges which limit the potential of risk information to
generate concern in people about their existing lifestyle.
The second theme identifies the advantages of the ‘heart
age’ format in generating concern about sub-optimal life-
style and awareness of the need to improve it. The third
theme is the impact of the website-based lifestyle interven-
tion on intentions and attempts to make moderate lifestyle
changes regardless of concerns about the CHD risk score.
1. The challenges limiting the potential of risk
information to generate concern about CHD risk
and existing lifestyle
Most of the participants were not concerned about
their risk scores but rather were happy with them,
or at least felt fine about them. This finding may be
expected for participants who received a risk score
that was optimal for their age. However, about
two thirds of the interviewees who received risk
scores had a ‘heart age’ that was older than their
chronological age, (i.e. their risk score was higher
than someone of the same age and sex with optimal
risk factors associated with CHD risk). Despite
this, only a minority of these participants were
concerned about their risk. Several explanations for
this lack of concern about the risk score emerged:
➢ Partial noticing and understanding of the risk
scores: four interview and two focus group
participants did not remember receiving risk
scores at all (our website records indicated that
all the interview and focus group participants
from groups 3 and 4 had accessed their risk score
page). Four others had only a vague recollection
of the risk score. Additionally, most of those who
did remember a risk score were able to recall only
one format of presentation, typically an absolute
risk score expressed as a percentage. Noticing a
percentage risk score without noticing any
additional comparative information, meant that
whether this was perceived as a high or low risk
was largely dependent on the participants’ own
preconceptions or on other lay persons opinion.
For example, a woman in her early 70s with a
phenotypic risk score of 9% remembered she
received a risk score of 8%. When asked how did
she feel about it she said: “I was quite concerned
but my husband didn’t think was very high!” and
later added that she was convinced by him that it
was not high. Another participant, also female
with a phenotypic risk score of 11 thought it was
a ‘decent score’. She did not notice her ‘heart age’
which was eight years older than her real age.
➢ Overestimation of own risk before the
intervention: Many of the participants held
overestimating preconceptions about their risk.
For example, while the mean of the actual
phenotypic risk score given to male interviewees
was 11.2%, their mean self-predicted score at
baseline was 33.1%. Among female participants
this was even more evident, with a mean
calculated risk score of 3.5% and a mean
self-predicted score of 29.5%.
➢ High threshold for what is a high risk: when
we asked participants who thought that their risk
score was fine what would constitute a high risk
in their view, 11 referred to 50% (another
commonly mentioned threshold was 10%
although there were participants who could not
name any threshold). Given this, it is not
surprising that risk scores of 10% or lower, and
Table 1 Characteristics of participants
Interviews Focus group
n = 41 n = 13
Gender
Male 23 9
Female 18 4
Age (years)
40–49 8 3
50–59 15 4
60–69 13 5
70–80 5 1
Study group
4 (genetic + phenotypic
risk + lifestyle advice)
22 8
3 (phenotypic risk + lifestyle advice) 15 5
2 (lifestyle only) 4 0
Mean (range) phenotypic risk score (% 10 year risk)
Male 12.6 (4–62) 6.6 (4–12)
Female 4.5 (1–11) 0.9 (1–2)
Marital status
Married 28 10
Separated or Divorced 3 1
Widowed 3 0
Single 7 2
Level of Education
No Formal education 1 0
Secondary education 17 5
University education 23 8
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for some over 20%, were not considered
concerning. The question of what is a high risk is
of course subjective, but some of the explanations
given by some participants as to why they felt a
risk below 50% was not concerning were quite
telling and suggested an vague understanding of
probability and risk. For example, one participant
commented: ‘[If the risk score is] over half way I
should probably do something about it’ (male
participant in his 60s, with phenotypic risk score
of 12% and genetic risk score of 13%), another
said that ‘to be in the top half sounds bad’ (female
interviewee in her 40s with a phenotypic and
genetic risk score of 1%). One participant said
specifically that ‘I tend to interpret it as being
obviously a percentage of the population, so 5%
risk to me is low. If it
was like 50% then that’d be different’
(male interviewee in his 50s with a phenotypic
risk score of 8 and genetic risk score of 6).
In addition to the general limitations of risk scores,
genetic risk scores seemed to be particularly irrelevant
to participants. Two thirds of the interviewees who
received genetic and phenotypic risk score either
didn’t remember them at all or remembered only one
risk score and did not remember whether or not it
was genetic. The participants also did not understand
the meaning of genetic risk score, and those who did
notice it interpreted its meaning in a fatalistic way. A
participant in one of the focus groups for example
commented:
“I’m just thinking if you have a high genetic risk it’s in
your genes, yes lifestyle has an impact but you’ve got
it in your genes, what happens then if you die because
of the genes? You’ve in a sense exercised yourself
potty, deprived yourself of all your nice treats but
you’ve still had the same end result. You might as well
have enjoyed it and gone!”
Another participant in a focus group commented
that if the genetic risk is high maybe the only
option is to go for ‘gene therapy’. A small number
of participants had a high genetic risk score
(reflected in a heart age older than their
chronological age) and a low phenotypic risk score.
They found the information particularly unhelpful
as they felt that they had a close to optimal lifestyle
and their phenotypic risk score and phenotypic
heart age confirmed it, and felt they could not do
anything about the high genetic risk score. One of
them, the most extreme example we had in our
sample in term of this disparity between the two
risk scores, was a woman in her mid 50s with a
phenotypic heart age of 49% and a genetic heart age
of 63. She said she was confused, commenting: “it
didn’t explain why it would be that way so I mean, I
haven’t sort of lost sleep over it but I did kind of
think why basically, why should it be that way?”
2. The powerful message carried by an older ‘heart age’
Notwithstanding the limitations of risks scores in
general, ‘heart age’ stood out as a type of risk score
presentation that, if noticed, and if higher than the
chronological age, communicated a powerful
message about how far from optimal the
participant’s lifestyle was. About a quarter of the
interviewees were concerned about their risk score
and almost all of them had noticed their ‘heart age’
and were concerned primarily about their ‘heart
age’. This is despite the fact that some of them had
a relatively high (above 20) percentage risk score.
For example, one participant, a male in his 50s,
who received a phenotypic risk score of 23%
and a ‘heart age’ that was 24 years older than his
chronological age, commented that ‘it was the heart
age that jumped out at me […] it was the heart age
that really shook me’.
For some, the ‘heart age’ also carried with it
additional symbolic messages. For example, one
participant in his late 50s was particularly
concerned that his ‘heart age’ was that of
retirement age (65), while he was still in full time
work: ‘It is a spur to be told that your risk is that of
somebody who’s retired so it just wakes me up to the
fact that I’ve got to be more active’.
Concerns about high ‘heart age’ did not
automatically create an intention to change lifestyle
(and, in one case, created an initial fatalistic
reaction), but for some participants it was a serious
‘wake up call’ that encouraged them to make
changes to their lifestyle. One participant in
particular reported making quite a radical change
to his lifestyle after finding out that his ‘heart age’
was 15 years older than his chronological age. He
joined a commercial weight-loss scheme, lost about
9 kg by the time of the interview, added wholegrain
products to his diet, started walking for half an
hour or more at least three times a week and cut
out sweets and desserts.
Other participants who were concerned about their
‘heart age’ attempted to make more moderate
lifestyle changes such as having less white bread or
increasing their fruit and vegetable intake. For
example, a male interviewee, in his late 50s, with a
phenotypic risk score of 11% and a heart age that
was 6 years older than his own age, explained the
reasons for the lifestyle changes he made following
the study (stopped drinking sugary drinks) in the
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following way, referring specifically to the ‘heart
age’ format or presentation: “the study sort of
nails things that you know about these things,
and it sort of nails it down, hang on a minute,
you’re actually running out of time here and
you’ve got to do it”.
3. The impact of the website-based lifestyle intervention
on intentions and attempts to make moderate
lifestyle changes
Reports of attempts to change lifestyle were,
however, not limited to participants who were
concerned about their high heart age. In fact, more
than two thirds of the interviewees, including more
than half of the interviewees who had risk scores
that were low or moderate for their age reported
not only intending and attempting to implement
some lifestyle changes during the study, but actually
being able to maintain the change at the time of the
interview or focus group (as for all the findings,
these are the results from the qualitative element of
the study). Typically, these changes were modest.
Among the lifestyle changes mentioned by
participants were the following: having salad for
lunch; adding one session of walking in the
weekends to pre-existing walking sessions during
weekdays; cutting out chocolate and wine; having
one more fish meal a week; buying a pedometer
and trying to increase the daily step count; having
some alcohol free evenings.
Some participants made more radical changes
regardless of their risk score. One interviewee who
was in the group receiving lifestyle advice only, a
woman in her 50s, reported making as radical a
change to her lifestyle as the person concerned by
his ‘heart age’ mentioned above. She stated that she
had lost about 8 kg, after some drastic changes to
her diet, moving to wholemeal food, and increasing
her number of daily steps from 7000 to 12,000.
When we asked participants what stimulated them
to make these changes in their lifestyle, many
explained that they were already aware of the need
to do something and had some idea of what they
could do to change their lifestyle but the study
acted as a ‘reminder’; ‘a trigger’; ‘a nudge’; a tool to
‘refocus awareness’. One of the participants, a male
in his late 60s with a phenotypic risk score of 9%
commented about his decision to consume more
fruits and vegetables and cut on his alcohol
consumption in the following words: “I think goal
setting helped me make the changes because I was
aware that both [fruit and veg consumption and
alcohol consumption, G.S] were wrong anyway, or
were out of balance, so it was quite an incitement
to do that, to change”
For others, the change in lifestyle was a
combination of the study being a trigger
encouraging them to do something they already
intended to do and a wish to help the study: ‘it gave
me the kick that I needed, and also it gives you that
kind of, ‘Oh, I’m helping. I’m involved in a study.’
(a female interviewee in her 40s with a phenotypic
risk score of 1% who did not receive genetic
risk score).
The lifestyle advice website was viewed as
instrumental in facilitating the change for
participants. While most participants were familiar
with the majority of the information and advice,
some participants reported learning new
information about some aspects of healthy lifestyle,
particularly regarding diet. Many participants found
the interactive format of the website, the personal
advice, the goal setting and more generally the
autonomy that they felt they had when deciding
what changes to do and when and how to do them
quite appealing. They explained that this approach
allowed them to attempt making changes in their
own pace and terms.
A particular repeated comment referred to the
non-preaching nature of the lifestyle website, in
comparison to interventions that participants had
encountered in the past. Their memories of other
interventions were that they were ‘lectured’ by
them, thus making them defensive and reluctant to
engage. One interviewee, a woman in her 60s with
a phenotypic risk score of 6% and a ‘heart age’
which was lower than her real age, commented,
for example:
“It gives you an opportunity to set your own target. So
you can make it as big a step or as small a step as you
like. It’s flexible and there’s nobody going to be there
with a, you know, a knife in your back if you don’t
do it, you know, there’s nobody looking over your
shoulder and saying, ‘You didn’t do such and such a
thing’.
Another interviewee, a man in his 50s, also with a
phenotypic risk score of 6% and with a ‘heart age’
which was lower than his real age, commented in a
similar fashion:
I thought it was pretty good, it was better than I
expected. I did wonder if it was going to lecture me
or try to frighten me, but I thought it was quite easy
to use, it was clear, the information was there and it
didn’t sort of judge you or anything. So I thought it
was quite good and I did the whole thing and that
was fine, yeah.
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Not all participants attempted to change their
lifestyle. There was a small group of participants
who felt that they did not learn anything new from
the advice given in the website and that their
lifestyle was already close to optimal. However,
none of the participants reported that they
intended to do less than they were doing before the
study because of receiving a risk score that was
lower than they expected. In other words, we did
not find evidence for false reassurance.
Discussion
Principal findings
The findings of this study reflect some of the challenges
and opportunities for using risk scores and lifestyle ad-
vice as part of a strategy to reduce the burden of cardio-
vascular disease. In relation to risk scores, the study
identifies some of the barriers limiting the potential of
risk scores to create concern about an individual’s prob-
ability of having CHD. Risk scores were frequently over-
looked and not meaningful, particularly genetic risk
scores, and significantly lower than prior perceptions.
Despite these limitations, a risk score in the format of
‘heart age’, if noticed and if higher than the chronological
age, can communicate a powerful message that an indi-
vidual’s CHD risk is not optimal. Regardless of risk-
scores, a user friendly, interactive, goal setting based life-
style advice website appeared to motivate individuals to
attempt to make modest changes in lifestyle [46].
Results in context
Many of the challenges of understanding and interpret-
ing risk scores have been reported previously [47, 48].
Our study shows, however, that using different risk score
presentation formats together, does not necessarily elim-
inate these challenges. Providing multiple types of pres-
entation does not automatically translate into increased
understanding. Individuals struggle to absorb the many
different types of information, and many of them notice
only one type of presentation and rarely more than two.
Combined with a preconception about what constitutes a
high risk, noticing only one type of risk information, is not
necessarily followed by a heightened concern about risk.
However, if individuals notice their ‘heart age’ then
even without any additional information it can provide a
‘full message’ about non optimal lifestyle. Age is a more
familiar, concrete and absolute concept than probability
and since people know their chronological age, it is quite
simple to communicate to them a message about their
lifestyle being less than optimal. Another main advan-
tage of a ‘heart age’ is that it can communicate a mes-
sage about non optimal lifestyle even at younger age,
when the absolute risk is likely to be quite low, thus po-
tentially encouraging younger people to change their
lifestyle at an age when lifestyle changes, if sustained,
can have a greater impact on decreasing risk of CHD.
These results are consistent with a recent randomised
controlled trial [24] that found ‘heart age’ to be more ef-
fective than other types of individual’s modelled CVD
risk in reducing risk scores. They are also consistent to a
large extent with a previous qualitative study that found
that heart age can motivate lifestyle change [27]. We did
not find decreased perceived credibility to this format of
presentation of risk scores reported by that and other
study [26], although if much higher than the actual age,
‘heart age’, like the genetic risk scores, can lead to some
fatalistic views about CVD risk.
There is some evidence that fear can have a positive
impact on attitudes and behaviour [49]. Some psycho-
logical theories of health-related behaviour change pos-
tulated that perceived risk can play a central role in
adoption of health-related behaviours [50]. For example,
in the Health Belief Model (HBM), this is reflected in
the concept of perceived threat, a combination of per-
ceived susceptibility and perceived severity [51]. This
study however indicates that other factors might be at
least as relevant for adoption of lifestyle changes which
may be in line with more recent health behaviour
change theories such as intention-implementation. This
finding is supported by the fact that many participants
attempted moderate changes to their lifestyle while be-
ing indifferent (or happy) about their risk.
Implications for clinical practice and future research
Risk information is being provided with increasing fre-
quency in routine consultations and as part of screening
and risk reduction programmes such as NHS Health
Checks [52]. Given the difficulties people appear to have
with understanding risk scores when presented in mul-
tiple formats, a simplified format of risk score presenta-
tion may be clearer, especially if used in the format of
‘heart age’. Other forms of risk information, such as the
percentage risk of developing disease over the next
10 years used widely within primary care and within the
NHS health checks, may be less useful and limited by
people’s tendency to overestimate their risk and intrinsic
difficulties understanding numbers and probabilities.
Genetic risk scores also appear to be less meaningful
and can lead to fatalistic responses as was very recently
suggested [29]. ‘Heart age’, however, can also lead to a fa-
talistic response as real age is irreversible and some par-
ticipants interpreted the heart age to imply that they are
older than their age and that ‘time is running out’. Any
strategy using either ‘heart age’ or genetic risk will,
therefore, need to put emphasis on clarifying that the
overall risk can still be reduced following a change in
lifestyle. For that purpose, a detailed explanation about
the increased risk as a result of individual’s genetic
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predisposition may be simpler to understand than calcu-
lating genetic risk scores.
The limited understanding and impact of the online
risk score information in this study suggests that some
individuals may benefit from risk information being pro-
vided face-to-face as part of a consultation with a health-
care practitioner. In such a consultation, the concept of
risk can be further discussed and interpreted and the
practitioner can answer patients’ questions and clarify
misunderstandings. However, previous studies have
shown that participant recall of risk is still very low even
after being given risk information face-to-face [16]. The
findings from this study also suggest that when conduct-
ing such consultations it is important to be aware of the
preference of some individuals to have more control on
the pace and nature of the lifestyle change without
feeling pushed too much by threatening messages and
overemphasising of the risk. Others may find an inter-
active, goal setting based internet site a useful trigger to
start the process of lifestyle change. This may of course
also be a cheaper alternative to face-to-face consulta-
tions [46].
Limitation and strengths
In addition to general limitations on the representative-
ness of small purposive samples in qualitative studies,
the participants in this trial may be less representative of
the general population. Our participants are blood do-
nors and participants in the INTERVAL study who are
likely to have better knowledge of and higher commit-
ment to healthier lifestyles. For example, the mean
phenotypic risk score of the participants of this study
was 12.6% for men and 4.5% for women while the mean
phenotypic risk score for participants in the population-
based EPIC-Norfolk study (from which risk score equa-
tions were derived) was 15.2% for men and 6.7% for
women respectively. The participants were also quite
highly educated with over half of the sample having had
a university education. These sample demographics
should be taken into account when interpreting our
findings; however they may actually add extra strength
to some of them. It is arguable, for example, that the
limitations in understanding and interpreting the risk
scores are likely to be even more considerable in people
with lower levels of education.
The relative short time scale of the study additionally
meant that we were not able to explore in depth the
challenges involved in maintaining lifestyle changes
over the longer term. We therefore cannot tell how
long any changes in lifestyle reported by participants
may last and what their impact might be on CHD risk.
Some of these questions may be addressed by the quan-
titative results of the INFORM trial but others may
require longer studies.
Conclusion
Provision of CHD risk information, for example as part
of NHS Health Checks in the UK is unlikely to have a
significant impact in and of itself, especially if absolute
risk is presented as a percentage. Genetic risk informa-
tion alone is also unlikely to motivate engagement in
risk-reducing behaviours. Using risk scores in the format
of ‘heart age’ can overcome limitations of other formats
of CHD risk score presentation and interactive persona-
lised lifestyle advice can generate motivation for lifestyle
advice even when participants are indifferent about their
risk scores.
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